معرفی
Robert Koenekoop is a Senior Scientist at the Research Institute of the McGill University Health Centre (IR-MUHC) at the Glen site, and a Professor in the Department of Pediatric Surgery, Faculty of Medicine and Health Sciences at McGill University. He works within the Department of Pediatric Surgery, Division of Ophthalmology at the McGill University Health Centre (MUHC) as part of the Child Health and Human Development Program at the Center for Translational Biology.
Dr. Koenekoop's research focuses on the discovery of genes and pathways linked to childhood blindness and the development of new treatments. His work spans several key areas including:
- Gene discovery for inherited retinal diseases
- Drug development for childhood blindness
- Genotyping approaches for retinal dystrophies
- Gene therapy interventions
His publication record demonstrates significant contributions to understanding and treating inherited retinal degenerations. Dr. Koenekoop has been instrumental in research on Leber congenital amaurosis, Usher syndrome, and other genetic eye disorders. His recent work shows a transition toward therapeutic applications, with active participation in multiple clinical trials. According to his website, his team in Montreal is currently participating in 5 therapy trials for childhood and adult blindness, including CRISPR-Cas treatments, gene editing approaches, gene replacement therapies, and oral treatments.
Dr. Koenekoop maintains an active research profile with publications in high-impact journals including the New England Journal of Medicine, Nature Genetics, The Lancet, and American Journal of Human Genetics. His work bridges basic science discoveries with clinical applications, aiming to translate genetic findings into therapeutic interventions for patients with inherited retinal diseases.
